Savara, Inc.
Key Metrics
Market Snapshot
About
Savara, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for rare respiratory diseases. The company's lead product candidate targets autoimmune pulmonary alveolar proteinosis (aPAP), a rare lung disorder. Savara is advancing novel therapies through clinical trials to address significant unmet medical needs.